Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Migraine
Age: Adult: greater than 18 years
Dose: Oral – 50-100 mg
Frequency: repeated at 2-hour intervals if migraine recurs
Note: Maximum: 200 mg/24 hours
Indication: Migraine
Age: Adult: greater than 18 years
Condition: Mild to moderate hepatic impairment
Dose: Oral – 50 mg
Note: Maximum single dose: 50 mg

Child Dose

Clinical InformationAdministration Information
Age: less than 18 years
Dose: Dose:
Note: Safety and efficacy not established
Administration
  • Can be taken with or without food
  • Take at first sign of migraine
Side Effect

Drug Interaction

Drug NameRisk Factors
Ergotamine and related compounds
Increased risk of vasospastic reaction
SSRI, MAOIs (Phenelzine, Tranylcypromine, Selegiline, Moclobemide)
Increased risk of serotonin syndrome

Disease Interaction

Disease NameRisk Factors
Basilar/Hemiplegic/Ophthalmoplegic Migraine
Can cause dangerous complications
History of MI/Stroke
Risk of cardiovascular events

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 20°C-25°C temperature. Do not store in the refrigerator or freezer. Do not test before use

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.